The role of mitochondrial nitric oxide synthase in inflammation and septic shock

被引:134
|
作者
Boveris, A [1 ]
Alvarez, S [1 ]
Navarro, A [1 ]
机构
[1] Univ Buenos Aires, Lab Free Radical Biol, Sch Pharm & Biochem, RA-1113 Buenos Aires, DF, Argentina
关键词
mtNOS; inflammation; septic shock; mitochondrial dysfunction; organ chemiluminescence; free radicals;
D O I
10.1016/S0891-5849(02)01009-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide and cytokines constitute the molecular markers and the intercellular messengers of inflammation and septic shock. Septic shock occurs with an exacerbated inflammatory response that damages tissue mitochondria. Skeletal muscle appears as one of the main target organs in septic shock, showing an increased nitric oxide (NO) production, an early oxidative stress, and contractile failure. Mitochondria isolated from rat and human skeletal muscle in septic shock show a markedly increased NO generation and a decreased state 3 respiration, more marked with nicotinamide adenine dinucleotide (NAD)-linked substrates than with succinate, without uncoupling or impairment of phosphorylation. One of the current hypothesis for the molecular mechanisms of septic shock is that the enhanced NO production by mitochondrial nitric oxide synthase(mtNOS) leads to excessive peroxynitrite (ONOO-) production and protein nitration in the mitochondrial matrix, to mitochondrial dysfunction and to contractile failure. Surface chemiluminescence is a useful assay to assess inflammation and oxidative stress in in situ liver and skeletal muscle. Liver chemiluminescence in inflammatory processes and phagocyte chemiluminescence have been found spectrally different from spontaneous liver chemiluminescence with increased 440-600 nm emission, likely due to NO and ONOO- participation in the reactions leading to the formation of excited species. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:1186 / 1193
页数:8
相关论文
共 50 条
  • [21] USE OF NITRIC-OXIDE SYNTHASE INHIBITORS AS A NOVEL TREATMENT FOR SEPTIC SHOCK
    WOLFE, TA
    DASTA, JF
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (01) : 36 - 46
  • [22] Nitric oxide synthase inhibitors - A mechanism-based treatment of septic shock
    Kilbourn, R
    CRITICAL CARE MEDICINE, 1999, 27 (05) : 857 - 858
  • [23] EFFECT OF NITRIC-OXIDE SYNTHASE INHIBITORS ON HYPOTENSION IN PATIENTS WITH SEPTIC SHOCK
    PETROS, A
    BENNETT, D
    VALLANCE, P
    LANCET, 1991, 338 (8782-3): : 1557 - 1558
  • [24] REVERSAL OF REFRACTORY HYPOTENSION IN SEPTIC SHOCK BY INHIBITOR OF NITRIC-OXIDE SYNTHASE
    LIN, PJ
    CHANG, CH
    CHANG, JP
    CHEST, 1994, 106 (02) : 626 - 629
  • [25] NITRIC-OXIDE SYNTHASE INHIBITION REDUCES VENOUS RETURN IN SEPTIC SHOCK
    SAETRE, T
    SMISETH, OA
    CARLSEN, H
    SCHOLZ, T
    NORDSLETTEN, L
    GUNDERSEN, Y
    AASEN, AO
    CIRCULATION, 1994, 90 (04) : 321 - 321
  • [26] Mitochondrial nitric oxide synthase
    Boveris, A
    FREE RADICAL RESEARCH, 2003, 37 : 17 - 17
  • [27] Mitochondrial nitric oxide synthase
    Brookes, PS
    MITOCHONDRION, 2004, 3 (04) : 187 - 204
  • [28] Mitochondrial nitric oxide synthase
    Ghafourifar, P
    Cadenas, E
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (04) : 190 - 195
  • [29] Mitochondrial nitric oxide synthase
    Ghafourifar, Pedram
    Sen, Chandan K.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 1072 - 1078
  • [30] Mitochondrial nitric oxide synthase
    Bates, TE
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S269 - S269